Disclaimer: This calculator is for informational purposes only and should not replace professional medical advice.
Welcome to the Aaron Graves, PhDude Replica's CTS5 Calculator! This tool is designed to help patients and healthcare professionals understand the Clinical Treatment Score for Breast Cancer (CTS5), a prognostic index used for estimating the 5-year risk of distant recurrence in patients with ER-positive, HER2-negative breast cancer.
What is the CTS5 Score?
The CTS5 score is a validated prognostic tool developed to predict the likelihood of distant recurrence in women with estrogen receptor (ER)-positive, HER2-negative breast cancer who have completed 5 years of endocrine therapy. It helps stratify patients into different risk groups (low, intermediate, high) for late distant recurrence, which can inform decisions about extended endocrine therapy.
Why is CTS5 Important?
Many patients with ER-positive breast cancer continue to face a risk of recurrence even after completing 5 years of adjuvant endocrine therapy. The CTS5 score helps to identify those patients who might benefit most from extended endocrine therapy (e.g., for 10 years instead of 5), and conversely, those who may not need it, thereby avoiding unnecessary side effects.
Factors Used in the CTS5 Calculation
The CTS5 score takes into account several key clinical and pathological factors:
- Patient Age: Age at diagnosis plays a role in recurrence risk.
- Tumor Size: The size of the primary tumor (in millimeters). Larger tumors generally indicate higher risk.
- Nodal Status: The number of positive lymph nodes. Involvement of lymph nodes is a significant prognostic factor.
- Histological Grade: The grade of the tumor, which describes how abnormal the cancer cells look under a microscope and how quickly they are growing (Grade 1: low, Grade 2: intermediate, Grade 3: high).
- Ki-67 Index: A proliferation marker, expressed as a percentage, indicating the proportion of cancer cells that are actively dividing. Higher Ki-67 levels are generally associated with more aggressive tumors.
How to Use This Calculator
To use the CTS5 calculator, simply input your relevant clinical and pathological data into the fields above. Ensure all values are accurate as provided by your pathology report or medical records. Once all fields are filled, click the "Calculate CTS5 Score" button to instantly receive your estimated score and risk category.
Interpreting Your Results
The calculator will provide a numerical CTS5 score and an associated risk category (Low, Intermediate, or High) for 5-year distant recurrence. These categories are general guidelines:
- Low Risk (CTS5 Score < 3.0): Typically suggests a low probability of distant recurrence within 5 years (e.g., < 5%).
- Intermediate Risk (CTS5 Score 3.0 to < 4.0): Indicates a moderate probability of distant recurrence (e.g., 5-10%).
- High Risk (CTS5 Score ≥ 4.0): Suggests a higher probability of distant recurrence (e.g., > 10%).
Important Note: The risk categories and associated percentages provided by this calculator are illustrative and based on commonly referenced thresholds from clinical studies. Actual clinical interpretation requires careful consideration of individual patient circumstances, other prognostic factors, and discussions with an oncologist. This tool is not a substitute for professional medical advice.
Disclaimer
This CTS5 calculator is provided for educational and informational purposes only. It is based on published clinical data and formulas but should not be used to make medical decisions. Always consult with a qualified healthcare professional for diagnosis, treatment, and medical advice specific to your condition. Aaron Graves, PhDude Replica does not guarantee the accuracy or applicability of the information provided for any individual case.